{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:02:00Z","timestamp":1791298920146,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"30","license":[{"start":{"date-parts":[[2012,9,3]],"date-time":"2012-09-03T00:00:00Z","timestamp":1346630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,9,3]],"date-time":"2012-09-03T00:00:00Z","timestamp":1346630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2013,7,25]]},"DOI":"10.1038\/onc.2012.363","type":"journal-article","created":{"date-parts":[[2012,9,3]],"date-time":"2012-09-03T14:30:10Z","timestamp":1346682610000},"page":"3500-3509","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":134,"title":["Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers"],"prefix":"10.1038","volume":"32","author":[{"given":"M K Y","family":"Siu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E S Y","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D S H","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H Y","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O G W","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E W-F","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K K L","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H Y S","family":"Ngan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X-F","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A N","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,3]]},"reference":[{"key":"BFonc2012363_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","volume":"57","author":"A Jemal","year":"2007","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ . Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43\u201366.","journal-title":"CA Cancer J Clin"},{"key":"BFonc2012363_CR2","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nrc1123","volume":"3","author":"R Agarwal","year":"2003","unstructured":"Agarwal R, Kaye SB . Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer 2003; 3: 502\u2013516.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2012363_CR3","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0092-8674(03)00392-1","volume":"113","author":"I Chambers","year":"2003","unstructured":"Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003; 113: 643\u2013655.","journal-title":"Cell"},{"key":"BFonc2012363_CR4","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0092-8674(03)00393-3","volume":"113","author":"K Mitsui","year":"2003","unstructured":"Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003; 113: 631\u2013642.","journal-title":"Cell"},{"key":"BFonc2012363_CR5","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0092-8674(03)00394-5","volume":"113","author":"F Cavaleri","year":"2003","unstructured":"Cavaleri F, Scholer HR . Nanog: a new recruit to the embryonic stem cell orchestra. Cell 2003; 113: 551\u2013552.","journal-title":"Cell"},{"key":"BFonc2012363_CR6","first-page":"5821","volume":"63","author":"SK Singh","year":"2003","unstructured":"Singh SK, Clarke ID, Terasaki M, Bonne VE, Hawkins C, Squire J et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821\u20135828.","journal-title":"Cancer Res"},{"key":"BFonc2012363_CR7","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1182\/blood-2005-06-2517","volume":"107","author":"CA Huff","year":"2006","unstructured":"Huff CA, Matsui W, Smith BD, Jones RJ . The paradox of response and survival in cancer therapeutics. Blood 2006; 107: 431\u2013434.","journal-title":"Blood"},{"key":"BFonc2012363_CR8","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.molmed.2008.08.003","volume":"14","author":"T Klonisch","year":"2008","unstructured":"Klonisch T, Wiechec E, Hombach-Klonisch S, Ande SR, Wesselborg S, Schulze-Osthoff K et al. Cancer stem cell markers in common cancers\u2014therapeutic implications. Trends Mol Med 2008; 14: 450\u2013460.","journal-title":"Trends Mol Med"},{"key":"BFonc2012363_CR9","first-page":"260","volume":"1","author":"Y Pan","year":"2008","unstructured":"Pan Y, Huang X . Epithelial ovarian cancer stem cells-a review. Int J Clin Exp Med 2008; 1: 260\u2013266.","journal-title":"Int J Clin Exp Med"},{"key":"BFonc2012363_CR10","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","volume":"68","author":"S Zhang","year":"2008","unstructured":"Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 2008; 68: 4311\u20134320.","journal-title":"Cancer Res"},{"key":"BFonc2012363_CR11","doi-asserted-by":"publisher","first-page":"11154","DOI":"10.1073\/pnas.0603672103","volume":"103","author":"PP Szotek","year":"2006","unstructured":"Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R et al. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci USA 2006; 103: 11154\u201311159.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2012363_CR12","doi-asserted-by":"publisher","first-page":"17635","DOI":"10.1074\/jbc.M800109200","volume":"283","author":"LY Bourguignon","year":"2008","unstructured":"Bourguignon LY, Peyrollier K, Xia W, Gilad E . Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J Biol Chem 2008; 283: 17635\u201317651.","journal-title":"J Biol Chem"},{"key":"BFonc2012363_CR13","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.cell.2005.08.020","volume":"122","author":"LA Boyer","year":"2005","unstructured":"Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005; 122: 947\u2013956.","journal-title":"Cell"},{"key":"BFonc2012363_CR14","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ajog.2008.01.005","volume":"198","author":"RJ Kurman","year":"2008","unstructured":"Kurman RJ, Visvanathan K, Roden R, Wu TC, Shih Ie M . Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obstet Gynecol 2008; 198: 351\u2013356.","journal-title":"Am J Obstet Gynecol"},{"key":"BFonc2012363_CR15","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1158\/0008-5472.CAN-07-5167","volume":"68","author":"K Sawada","year":"2008","unstructured":"Sawada K, Mitra AK, Radjabi AR, Bhaskar V, Kistner EO, Tretiakova M et al. Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target. Cancer Res 2008; 68: 2329\u20132339.","journal-title":"Cancer Res"},{"key":"BFonc2012363_CR16","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nrc2223","volume":"7","author":"SS Myatt","year":"2007","unstructured":"Myatt SS, Lam EW . The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer 2007; 7: 847\u2013859.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2012363_CR17","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1158\/1535-7163.MCT-08-0398","volume":"7","author":"S Fernandez de Mattos","year":"2008","unstructured":"Fernandez de Mattos S, Villalonga P, Clardy J, Lam EW . FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells. Mol Cancer Ther 2008; 7: 3237\u20133246.","journal-title":"Mol Cancer Ther"},{"key":"BFonc2012363_CR18","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/sj.bjc.6605626","volume":"102","author":"L Hu","year":"2010","unstructured":"Hu L, McArthur C, Jaffe RB . Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant. Br J Cancer 2010; 102: 1276\u20131283.","journal-title":"Br J Cancer"},{"key":"BFonc2012363_CR19","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/stem.29","volume":"27","author":"CR Jeter","year":"2009","unstructured":"Jeter CR, Badeaux M, Choy G, Chandra D, Patrawala L, Liu C et al. Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 2009; 27: 993\u20131005.","journal-title":"Stem Cells"},{"key":"BFonc2012363_CR20","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1158\/1078-0432.CCR-07-4404","volume":"14","author":"SH Chiou","year":"2008","unstructured":"Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ, Tsai TH et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 2008; 14: 4085\u20134095.","journal-title":"Clin Cancer Res"},{"key":"BFonc2012363_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/jcp.21667","volume":"219","author":"R Di Fiore","year":"2009","unstructured":"Di Fiore R, Santulli A, Ferrante RD, Giuliano M, De Blasio A, Messina C et al. Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment. J Cell Physiol 2009; 219: 301\u2013313.","journal-title":"J Cell Physiol"},{"key":"BFonc2012363_CR22","first-page":"25","volume-title":"Human Cell","author":"AP Wilson","year":"1999","unstructured":"Wilson AP, Garner CM . Ovarian cancer. Human Cell. Kluwer Academic Publishers: Boston, MA, USA, 1999, pp 25."},{"key":"BFonc2012363_CR23","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0889-8588(03)00061-3","volume":"17","author":"JD Seidman","year":"2003","unstructured":"Seidman JD, Kurman RJ . Pathology of ovarian carcinoma. Hematol Oncol Clin North Am 2003; 17: 909\u2013925.","journal-title":"Hematol Oncol Clin North Am"},{"key":"BFonc2012363_CR24","first-page":"186","volume":"18","author":"RP Perez","year":"1991","unstructured":"Perez RP, Godwin AK, Hamilton TC, Ozols RF . Ovarian cancer biology. Semin Oncol 1991; 18: 186\u2013204.","journal-title":"Semin Oncol"},{"key":"BFonc2012363_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1290\/1071-2690(2000)036<0357:COFNEO>2.0.CO;2","volume":"36","author":"DM Provencher","year":"2000","unstructured":"Provencher DM, Lounis H, Champoux L, Tetrault M, Manderson EN, Wang JC et al. Characterization of four novel epithelial ovarian cancer cell lines. In Vitro Cell Dev Biol Anim 2000; 36: 357\u2013361.","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"BFonc2012363_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/07357900802146204","volume":"27","author":"M Fei","year":"2009","unstructured":"Fei M, Zhao Y, Wang Y, Lu M, Cheng C, Huang X et al. Low expression of Foxo3a is associated with poor prognosis in ovarian cancer patients. Cancer Invest 2009; 27: 52\u201359.","journal-title":"Cancer Invest"},{"key":"BFonc2012363_CR27","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2353\/ajpath.2008.080288","volume":"173","author":"MK Siu","year":"2008","unstructured":"Siu MK, Wong ES, Chan HY, Ngan HY, Chan KY, Cheung AN . Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome. Am J Pathol 2008; 173: 1165\u20131172.","journal-title":"Am J Pathol"},{"key":"BFonc2012363_CR28","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/S0002-9440(10)61228-X","volume":"167","author":"S Miotti","year":"2005","unstructured":"Miotti S, Tomassetti A, Facetti I, Sanna E, Berno V, Canevari S . Simultaneous expression of caveolin-1 and E-cadherin in ovarian carcinoma cells stabilizes adherens junctions through inhibition of src-related kinases. Am J Pathol 2005; 167: 1411\u20131427.","journal-title":"Am J Pathol"},{"key":"BFonc2012363_CR29","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/ijc.2910580315","volume":"58","author":"AL Veatch","year":"1994","unstructured":"Veatch AL, Carson LF, Ramakrishnan S . Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells. Int J Cancer 1994; 58: 393\u2013399.","journal-title":"Int J Cancer"},{"key":"BFonc2012363_CR30","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/S0046-8177(97)90007-1","volume":"28","author":"E Darai","year":"1997","unstructured":"Darai E, Scoazec JY, Walker-Combrouze F, Mlika-Cabanne N, Feldmann G, Madelenat P et al. Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: a clinicopathologic study of 60 cases. Hum Pathol 1997; 28: 922\u2013928.","journal-title":"Hum Pathol"},{"key":"BFonc2012363_CR31","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1126\/science.1093889","volume":"303","author":"L Lin","year":"2004","unstructured":"Lin L, Spoor MS, Gerth AJ, Brody SL, Peng SL . Modulation of Th1 activation and inflammation by the NF-kappaB repressor Foxj1. Science 2004; 303: 1017\u20131020.","journal-title":"Science"},{"key":"BFonc2012363_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/gcc.20620","volume":"48","author":"B Demircan","year":"2009","unstructured":"Demircan B, Dyer LM, Gerace M, Lobenhofer EK, Robertson KD, Brown KD . Comparative epigenomics of human and mouse mammary tumors. Genes Chromosomes Cancer 2009; 48: 83\u201397.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFonc2012363_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/ijc.25005","volume":"127","author":"MK Siu","year":"2010","unstructured":"Siu MK, Wong ES, Chan HY, Kong DS, Woo NW, Tam KF et al. Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion. Int J Cancer 2010; 127: 21\u201331.","journal-title":"Int J Cancer"},{"key":"BFonc2012363_CR34","doi-asserted-by":"publisher","first-page":"18622","DOI":"10.1073\/pnas.0907481107","volume":"107","author":"MK Siu","year":"2010","unstructured":"Siu MK, Chan HY, Kong DS, Wong ES, Wong OG, Ngan HY et al. p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients. Proc Natl Acad Sci USA 2010; 107: 18622\u201318627.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2012363_CR35","doi-asserted-by":"publisher","first-page":"19245","DOI":"10.1074\/jbc.M208134200","volume":"278","author":"A Mansouri","year":"2003","unstructured":"Mansouri A, Ridgway LD, Korapati AL, Zhang Q, Tian L, Wang Y et al. Sustained activation of JNK\/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. J Biol Chem 2003; 278: 19245\u201319256.","journal-title":"J Biol Chem"},{"key":"BFonc2012363_CR36","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/ijc.2910480613","volume":"48","author":"SC Mann","year":"1991","unstructured":"Mann SC, Andrews PA, Howell SB . Modulation of cis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cells. Int J Cancer 1991; 48: 866\u2013872.","journal-title":"Int J Cancer"},{"key":"BFonc2012363_CR37","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/1476-4598-9-318","volume":"9","author":"L Jiang","year":"2010","unstructured":"Jiang L, Siu MK, Wong OG, Tam KF, Lam EW, Ngan HY et al. Overexpression of proto-oncogene FBI-1 activates membrane type 1-matrix metalloproteinase in association with adverse outcome in ovarian cancers. Mol Cancer 2010; 9: 318.","journal-title":"Mol Cancer"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2012363.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2012363","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2012363.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:13:01Z","timestamp":1647886381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2012363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,3]]},"references-count":37,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2013,7,25]]}},"alternative-id":["BFonc2012363"],"URL":"https:\/\/doi.org\/10.1038\/onc.2012.363","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,3]]},"assertion":[{"value":"29 September 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}